Drug giant cautions Australia on PBS wait times

US pharmaceutical company Eli Lilly has said it may pull clinical trial funding from Australia if PBS wait times aren’t reduced The drug giant’s head of international operations said Ilya Yuffa told the Australian Financial Review he hasn’t seen much progress on the Pharmaceutical Benefits Scheme (PBS) in his three-and-a-half years in his role. Eli